학술논문
Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adults
Document Type
Article
Author
Source
In: The Lancet Infectious Diseases . (The Lancet Infectious Diseases, October 2023, 23(10):1186-1196)
Subject
Language
English
ISSN
14744457
14733099
14733099